How AMH Levels Affect the Success Rate of IVF in the U.S. and Mexico

2025-10-29 19:32:03，浏览量： 2次

 

Before choosing IVF treatment in the U.S. or Mexico, understanding ovarian function is a crucial first step. AMH (Anti-Müllerian Hormone) levels are an important indicator for evaluating a woman’s ovarian reserve and are widely used to assess the success rate of IVF-PGT. For women planning to undergo IVF, egg freezing, or fertility preparation in the U.S. or Mexico, AMH test results often determine the direction of the treatment plan.

 

AMH levels reflect both the quantity and quality of follicles in the ovaries. Generally, the normal AMH range is between 2 and 6.8. The higher the value, the greater the ovarian reserve, and the higher the chances of retrieving mature eggs for fertilization. Reproductive specialists in the U.S. generally believe that an AMH level of 1 is the minimum required to start an IVF cycle, while a value above 3 indicates optimal ovarian function and a greater likelihood of obtaining quality eggs. For women considering egg freezing, higher AMH levels also serve as a key reference for evaluating egg quantity and viability.

 

One of the advantages of AMH testing is its stability, convenience, and accuracy. Unlike other hormonal indicators, AMH levels are not affected by the menstrual cycle, allowing women to take the test at any time. This flexibility makes fertility planning and IVF cycle scheduling easier. Moreover, AMH levels can reflect early changes in ovarian function, helping doctors detect declining ovarian reserves in advance. For older women or those who have struggled with conception for a long time, this test provides valuable clinical guidance.

 

A low AMH level does not mean that pregnancy is impossible. Fertility centers in the U.S. and Mexico often use personalized ovarian stimulation protocols to improve egg retrieval and combine them with IVF-PGT technology. By screening embryos for chromosomal abnormalities, only healthy embryos are selected for transfer, significantly improving pregnancy outcomes. This approach is especially beneficial for older women, as it reduces the risks of miscarriage, repeated implantation failure, and genetic abnormalities.

 

Globally, the U.S. and Mexico have become leading destinations for fertility treatment due to their advanced medical systems and flexible legal environments. In particular, Mexico’s egg-freezing programs have attracted many professional women with their cost-effectiveness and expert medical teams, allowing greater control over family planning. Meanwhile, the U.S. continues to lead with its highly successful IVF-PGT programs, offering reliable options for families pursuing healthy pregnancies.

 

Although fertility decline is irreversible, scientific assessment and timely intervention can help slow the process. Understanding your AMH levels is not only the first step in fertility preparation but also a way to take control of your reproductive health. Whether choosing IVF in the U.S. or egg freezing in Mexico, professional guidance and evidence-based treatment are key to turning the dream of parenthood into reality.

Founded by Dr. Nathan Zhang, IVF USA has been providing international fertility consulting services for more than a decade, offering U.S. egg freezing, IVF, and third-party reproductive solutions. With nearly 20 years of experience in global assisted reproduction, IVF USA has expanded its reach into Mexico to meet the growing demand for diverse and personalized fertility options. The organization serves as the official representative of Power Fertility Center Mexico (POWER IVF) in China. Under Dr. Nathan Zhang’s leadership, the network now extends beyond the U.S. to include IVF and egg freezing programs in Mexico, Japan, Thailand, Taiwan, and Hong Kong. With a rigorous and professional approach, the team at IVF USA continues to guide hopeful parents toward a clearer, more confident path to creating new life.